nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolbutamide—KCNJ1—forebrain—attention deficit hyperactivity disorder	0.0559	0.0911	CbGeAlD
Tolbutamide—ABCC8—forebrain—attention deficit hyperactivity disorder	0.0312	0.0509	CbGeAlD
Tolbutamide—KCNJ1—nervous system—attention deficit hyperactivity disorder	0.0303	0.0495	CbGeAlD
Tolbutamide—KCNJ1—central nervous system—attention deficit hyperactivity disorder	0.0292	0.0476	CbGeAlD
Tolbutamide—KCNJ11—cardiovascular system—attention deficit hyperactivity disorder	0.0287	0.0467	CbGeAlD
Tolbutamide—ABCC8—cardiovascular system—attention deficit hyperactivity disorder	0.0264	0.0431	CbGeAlD
Tolbutamide—SLCO2B1—forebrain—attention deficit hyperactivity disorder	0.0244	0.0399	CbGeAlD
Tolbutamide—KCNJ1—brain—attention deficit hyperactivity disorder	0.0232	0.0378	CbGeAlD
Tolbutamide—SLCO1A2—forebrain—attention deficit hyperactivity disorder	0.0225	0.0367	CbGeAlD
Tolbutamide—ABCC8—midbrain—attention deficit hyperactivity disorder	0.0206	0.0336	CbGeAlD
Tolbutamide—KCNJ11—nervous system—attention deficit hyperactivity disorder	0.0184	0.03	CbGeAlD
Tolbutamide—KCNJ11—central nervous system—attention deficit hyperactivity disorder	0.0177	0.0289	CbGeAlD
Tolbutamide—KCNJ11—cerebellum—attention deficit hyperactivity disorder	0.0173	0.0282	CbGeAlD
Tolbutamide—ABCC8—nervous system—attention deficit hyperactivity disorder	0.0169	0.0276	CbGeAlD
Tolbutamide—ABCC8—central nervous system—attention deficit hyperactivity disorder	0.0163	0.0266	CbGeAlD
Tolbutamide—ABCC8—cerebellum—attention deficit hyperactivity disorder	0.0159	0.026	CbGeAlD
Tolbutamide—SLC22A6—brain—attention deficit hyperactivity disorder	0.0149	0.0243	CbGeAlD
Tolbutamide—SLCO1A2—midbrain—attention deficit hyperactivity disorder	0.0148	0.0242	CbGeAlD
Tolbutamide—KCNJ11—brain—attention deficit hyperactivity disorder	0.0141	0.0229	CbGeAlD
Tolbutamide—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A9—attention deficit hyperactivity disorder	0.0133	0.0344	CbGpPWpGaD
Tolbutamide—SLCO2B1—nervous system—attention deficit hyperactivity disorder	0.0133	0.0216	CbGeAlD
Tolbutamide—ABCC8—brain—attention deficit hyperactivity disorder	0.013	0.0211	CbGeAlD
Tolbutamide—SLCO2B1—central nervous system—attention deficit hyperactivity disorder	0.0128	0.0208	CbGeAlD
Tolbutamide—SLCO2B1—cerebellum—attention deficit hyperactivity disorder	0.0125	0.0204	CbGeAlD
Tolbutamide—ABCC8—Regulation of insulin secretion—ADRA2C—attention deficit hyperactivity disorder	0.0124	0.032	CbGpPWpGaD
Tolbutamide—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A9—attention deficit hyperactivity disorder	0.0124	0.0319	CbGpPWpGaD
Tolbutamide—SLC15A2—midbrain—attention deficit hyperactivity disorder	0.0123	0.0201	CbGeAlD
Tolbutamide—SLCO1A2—nervous system—attention deficit hyperactivity disorder	0.0122	0.0199	CbGeAlD
Tolbutamide—KCNJ11—Regulation of insulin secretion—ADRA2C—attention deficit hyperactivity disorder	0.012	0.031	CbGpPWpGaD
Tolbutamide—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.0118	0.0192	CbGeAlD
Tolbutamide—SLCO1A2—central nervous system—attention deficit hyperactivity disorder	0.0118	0.0192	CbGeAlD
Tolbutamide—KCNJ1—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.0117	0.0301	CbGpPWpGaD
Tolbutamide—SLCO1A2—cerebellum—attention deficit hyperactivity disorder	0.0115	0.0187	CbGeAlD
Tolbutamide—SLCO2B1—brain—attention deficit hyperactivity disorder	0.0101	0.0165	CbGeAlD
Tolbutamide—SLC15A2—nervous system—attention deficit hyperactivity disorder	0.0101	0.0165	CbGeAlD
Tolbutamide—SLC15A2—central nervous system—attention deficit hyperactivity disorder	0.00975	0.0159	CbGeAlD
Tolbutamide—ABCC8—Integration of energy metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00973	0.0251	CbGpPWpGaD
Tolbutamide—SLC15A2—cerebellum—attention deficit hyperactivity disorder	0.00953	0.0155	CbGeAlD
Tolbutamide—KCNJ11—Integration of energy metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00943	0.0244	CbGpPWpGaD
Tolbutamide—SLCO1A2—brain—attention deficit hyperactivity disorder	0.00933	0.0152	CbGeAlD
Tolbutamide—ABCC8—Regulation of insulin secretion—CACNB2—attention deficit hyperactivity disorder	0.00854	0.0221	CbGpPWpGaD
Tolbutamide—KCNJ11—Regulation of insulin secretion—CACNB2—attention deficit hyperactivity disorder	0.00828	0.0214	CbGpPWpGaD
Tolbutamide—ABCC8—Regulation of insulin secretion—CACNA1C—attention deficit hyperactivity disorder	0.00781	0.0202	CbGpPWpGaD
Tolbutamide—SLC15A2—brain—attention deficit hyperactivity disorder	0.00774	0.0126	CbGeAlD
Tolbutamide—KCNJ11—Regulation of insulin secretion—CACNA1C—attention deficit hyperactivity disorder	0.00758	0.0196	CbGpPWpGaD
Tolbutamide—SLCO2B1—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.00711	0.0184	CbGpPWpGaD
Tolbutamide—ABCC8—Regulation of insulin secretion—SNAP25—attention deficit hyperactivity disorder	0.00683	0.0177	CbGpPWpGaD
Tolbutamide—ABCC8—Integration of energy metabolism—CACNB2—attention deficit hyperactivity disorder	0.00672	0.0174	CbGpPWpGaD
Tolbutamide—KCNJ11—Regulation of insulin secretion—SNAP25—attention deficit hyperactivity disorder	0.00662	0.0171	CbGpPWpGaD
Tolbutamide—CYP2C8—brain—attention deficit hyperactivity disorder	0.00652	0.0106	CbGeAlD
Tolbutamide—KCNJ11—Integration of energy metabolism—CACNB2—attention deficit hyperactivity disorder	0.00651	0.0168	CbGpPWpGaD
Tolbutamide—ABCC8—Regulation of insulin secretion—ADRA2A—attention deficit hyperactivity disorder	0.0065	0.0168	CbGpPWpGaD
Tolbutamide—KCNJ11—Regulation of insulin secretion—ADRA2A—attention deficit hyperactivity disorder	0.0063	0.0163	CbGpPWpGaD
Tolbutamide—ABCC8—Integration of energy metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00614	0.0159	CbGpPWpGaD
Tolbutamide—KCNJ1—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00597	0.0154	CbGpPWpGaD
Tolbutamide—ABCC8—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00596	0.0154	CbGpPWpGaD
Tolbutamide—KCNJ11—Integration of energy metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00596	0.0154	CbGpPWpGaD
Tolbutamide—SLC15A2—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.00595	0.0154	CbGpPWpGaD
Tolbutamide—KCNJ11—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00578	0.0149	CbGpPWpGaD
Tolbutamide—SLC15A1—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.00552	0.0143	CbGpPWpGaD
Tolbutamide—ABCC8—Integration of energy metabolism—SNAP25—attention deficit hyperactivity disorder	0.00537	0.0139	CbGpPWpGaD
Tolbutamide—KCNJ11—Integration of energy metabolism—SNAP25—attention deficit hyperactivity disorder	0.00521	0.0135	CbGpPWpGaD
Tolbutamide—KCNJ1—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00513	0.0133	CbGpPWpGaD
Tolbutamide—ABCC8—Integration of energy metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00511	0.0132	CbGpPWpGaD
Tolbutamide—KCNJ11—Integration of energy metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00496	0.0128	CbGpPWpGaD
Tolbutamide—KCNJ1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00477	0.0123	CbGpPWpGaD
Tolbutamide—SLCO1A2—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.00436	0.0113	CbGpPWpGaD
Tolbutamide—KCNJ1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00425	0.011	CbGpPWpGaD
Tolbutamide—SLC22A6—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.0041	0.0106	CbGpPWpGaD
Tolbutamide—CYP2C18—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00396	0.0102	CbGpPWpGaD
Tolbutamide—KCNJ1—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00362	0.00935	CbGpPWpGaD
Tolbutamide—SLCO2B1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00361	0.00934	CbGpPWpGaD
Tolbutamide—KCNJ1—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00359	0.00928	CbGpPWpGaD
Tolbutamide—SLCO2B1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00345	0.00891	CbGpPWpGaD
Tolbutamide—ABCC8—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00336	0.00868	CbGpPWpGaD
Tolbutamide—CYP2C19—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00325	0.0084	CbGpPWpGaD
Tolbutamide—ABCC8—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.0032	0.00828	CbGpPWpGaD
Tolbutamide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.00314	0.00811	CbGpPWpGaD
Tolbutamide—ABCC8—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00305	0.00788	CbGpPWpGaD
Tolbutamide—SLC15A2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00302	0.00781	CbGpPWpGaD
Tolbutamide—KCNJ11—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00296	0.00764	CbGpPWpGaD
Tolbutamide—SLC15A2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00288	0.00745	CbGpPWpGaD
Tolbutamide—SLC15A1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00281	0.00725	CbGpPWpGaD
Tolbutamide—CYP2C18—FOXA1 transcription factor network—EP300—attention deficit hyperactivity disorder	0.00271	0.00699	CbGpPWpGaD
Tolbutamide—SLC15A1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00268	0.00692	CbGpPWpGaD
Tolbutamide—ABCC8—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00262	0.00678	CbGpPWpGaD
Tolbutamide—KCNJ11—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00254	0.00657	CbGpPWpGaD
Tolbutamide—SLCO2B1—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00247	0.00639	CbGpPWpGaD
Tolbutamide—ABCC8—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00244	0.0063	CbGpPWpGaD
Tolbutamide—KCNJ11—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00236	0.00611	CbGpPWpGaD
Tolbutamide—SLCO1A2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00222	0.00573	CbGpPWpGaD
Tolbutamide—ABCC8—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00217	0.00562	CbGpPWpGaD
Tolbutamide—CYP2C18—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00212	0.00548	CbGpPWpGaD
Tolbutamide—SLCO1A2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00211	0.00546	CbGpPWpGaD
Tolbutamide—KCNJ11—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00211	0.00545	CbGpPWpGaD
Tolbutamide—CYP2C18—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.0021	0.00544	CbGpPWpGaD
Tolbutamide—CYP2C18—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00209	0.0054	CbGpPWpGaD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00208	0.00538	CbGpPWpGaD
Tolbutamide—SLC15A2—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00207	0.00535	CbGpPWpGaD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00199	0.00514	CbGpPWpGaD
Tolbutamide—SLC15A1—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00192	0.00497	CbGpPWpGaD
Tolbutamide—ABCC8—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00185	0.00478	CbGpPWpGaD
Tolbutamide—ABCC8—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00183	0.00474	CbGpPWpGaD
Tolbutamide—KCNJ11—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00179	0.00463	CbGpPWpGaD
Tolbutamide—KCNJ11—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00178	0.0046	CbGpPWpGaD
Tolbutamide—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00165	0.00426	CbGpPWpGaD
Tolbutamide—SLCO1A2—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00152	0.00392	CbGpPWpGaD
Tolbutamide—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00147	0.0038	CbGpPWpGaD
Tolbutamide—SLC22A6—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00143	0.00369	CbGpPWpGaD
Tolbutamide—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00134	0.00347	CbGpPWpGaD
Tolbutamide—SLCO2B1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00126	0.00325	CbGpPWpGaD
Tolbutamide—ABCC8—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00117	0.00302	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00111	0.00288	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00108	0.00279	CbGpPWpGaD
Tolbutamide—SLC15A2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00105	0.00272	CbGpPWpGaD
Tolbutamide—SLC15A1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000976	0.00252	CbGpPWpGaD
Tolbutamide—CYP2C8—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000882	0.00228	CbGpPWpGaD
Tolbutamide—CYP2C8—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000876	0.00226	CbGpPWpGaD
Tolbutamide—CYP2C8—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00087	0.00225	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000867	0.00224	CbGpPWpGaD
Tolbutamide—CYP2C19—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000787	0.00204	CbGpPWpGaD
Tolbutamide—CYP2C19—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000782	0.00202	CbGpPWpGaD
Tolbutamide—CYP2C19—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000777	0.00201	CbGpPWpGaD
Tolbutamide—SLCO1A2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000771	0.00199	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000768	0.00199	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000768	0.00199	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000756	0.00195	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000745	0.00192	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000745	0.00192	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000734	0.0019	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000733	0.00189	CbGpPWpGaD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000725	0.00187	CbGpPWpGaD
Tolbutamide—CYP2C9—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000718	0.00186	CbGpPWpGaD
Tolbutamide—CYP2C9—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000713	0.00184	CbGpPWpGaD
Tolbutamide—CYP2C9—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000708	0.00183	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000702	0.00182	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000681	0.00176	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000614	0.00159	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000598	0.00155	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000598	0.00155	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000595	0.00154	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000589	0.00152	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000584	0.00151	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000567	0.00146	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000547	0.00141	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000507	0.00131	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000507	0.00131	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000499	0.00129	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000478	0.00124	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—COMT—attention deficit hyperactivity disorder	0.000465	0.0012	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000464	0.0012	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000462	0.00119	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000455	0.00118	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—COMT—attention deficit hyperactivity disorder	0.000451	0.00117	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000448	0.00116	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000405	0.00105	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000386	0.000997	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—COMT—attention deficit hyperactivity disorder	0.000362	0.000937	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000361	0.000933	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—MAOA—attention deficit hyperactivity disorder	0.00036	0.00093	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000322	0.000832	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000307	0.000794	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000305	0.000788	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000296	0.000764	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000294	0.000759	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000249	0.000644	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000249	0.000644	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000245	0.000633	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000228	0.000589	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000222	0.000575	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000222	0.000575	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000219	0.000565	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000203	0.000526	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000203	0.000524	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000203	0.000524	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—EP300—attention deficit hyperactivity disorder	0.0002	0.000516	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000199	0.000515	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000199	0.000515	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—EP300—attention deficit hyperactivity disorder	0.000193	0.0005	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00019	0.00049	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000185	0.000479	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000178	0.000459	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000169	0.000437	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000162	0.000419	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—EP300—attention deficit hyperactivity disorder	0.000155	0.000402	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000154	0.000399	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—COMT—attention deficit hyperactivity disorder	0.000151	0.00039	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—MAOA—attention deficit hyperactivity disorder	0.00015	0.000387	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000145	0.000376	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	0.000135	0.000348	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000134	0.000346	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—EP300—attention deficit hyperactivity disorder	0.000132	0.00034	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.00013	0.000335	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	0.000123	0.000317	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000122	0.000315	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000118	0.000306	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—EP300—attention deficit hyperactivity disorder	6.47e-05	0.000167	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	5.78e-05	0.000149	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	5.27e-05	0.000136	CbGpPWpGaD
